The effect of tocilizumab, anakinra and prednisolone on antibody response to SARS-CoV-2 in patients with COVID-19: A prospective cohort study with multivariate analysis of factors affecting the antibody response.

Int J Infect Dis · 2021 · PMC7959682 · PMID 33737128

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

did not reach statistical significancep = 0.064so close (0.05 < p ≤ 0.1)

Although serum D-dimer levels were found to be higher, and blood lymphocyte counts were found to be lower among patients with a positive SARS-CoV-2 spike IgG, the differences did not reach statistical significance (p = 0.064 and p = 0.07, respectively) ( Table 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.